Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

FDA announces more recalls due to risk of syringe breaking during treatment
Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.
CCTA brings clarity, better outcomes to CTO PCI
Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.
Physicians chime in: Coronary plaque staging offers more precise cardiac patient management
As precision cardiology continues to evolve, the integration of advanced coronary computed tomography angiography (CCTA) and AI-driven analysis is fundamentally changing how we assess and manage coronary artery disease (CAD). Here is a closer look at how Heartflow Plaque Staging is leveraging Total Plaque Volume (TPV) to stratify patient risk.
SCCT President: Key trends in cardiac CT
As CCTA sees rapid adoption across cardiology, SCCT is working to address the education required to sustain the expansion.
Leveraging IT and AI to transform 3D imaging lab workflows at Banner Health
Procedure planning studies that once took hours can now be completed in just 25 minutes with 3D technology advances and AI.

AI model predicts risk of post-operative AFib

Post-operative atrial fibrillation was once viewed as a fairly insignificant issue, but more recent research suggests it can increase a patient’s risk of multiple adverse events.

Samir Kapadia, MD, chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute at Cleveland Clinic, explains why he believes the results of the late-breaking PROTECTED TAVR testing the use of a TAVR cerebral protection device were positive, although it did not meet its primary endpoint.

VIDEO: Exploring the use of cerebral protection devices during TAVR

Samir Kapadia, MD, chair of the department of cardiovascular medicine at Cleveland Clinic, shared his perspective on the use of cerebral protection devices during TAVR procedures.

Abbott FlexAbility Sensor Enabled Ablation Catheter FDA

Abbott gains new FDA approval for one catheter, CE mark approval for a second catheter

Both devices were approved for treating significant heart rhythm issues.

Coronary IVL now recommended at all cath labs, even those without surgical backup

The latest SCAI guidance on the safety of PCI procedures included a key change that could expand coronary IVL utilization throughout the United States.

Example of a cardiovascular information system (CVIS) cath lab reporting module with a coronary tree model that will auto complete sections of the report based on how the cardiologist modifies the model. Image from the ScImage booth at ACC 2022. Photo by Dave Fornell

VIDEO: 4 key trends in cardiovascular information systems, according to Signify Reseach

Signify Research shares the latest big trends in cardiovascular IT systems, including the role of EMR cardiology modules vs. third-party CVIS, structured reporting, integration into enterprise imaging and inclusion of ambulatory surgical centers.

CardiacSense, an Israel-based healthcare technology company, gained FDA clearance for its CSF-3 medical watch

Regulatory Roundup: FDA clears new medical watch, considers empagliflozin for CKD and much more

Our monthly review of FDA-related news items in the world of cardiology includes updates from CardiacSense, MedAlliance, Lupin, Realize Medical and Eli Lilly and Company.

Interventional cardiologists can safely perform PCI without on-site surgical backup

The finding comes from a new expert consensus statement published by the Society for Cardiovascular Angiography and Interventions. Several industry societies, including the ACC and AHA, have endorsed the document.

FDA issues new recall for circulatory support system after software update

The device was first recalled in 2022, but a new software update has now been released that addresses the issue. The FDA wanted a new recall to be issued to ensure all customers went through with the update.

Cardiac Imaging

FDA announces more recalls due to risk of syringe breaking during treatment

CCTA brings clarity, better outcomes to CTO PCI

Physicians chime in: Coronary plaque staging offers more precise cardiac patient management

SCCT President: Key trends in cardiac CT

Leveraging IT and AI to transform 3D imaging lab workflows at Banner Health